| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |